phenylbutazone has been researched along with n-formylmethionine leucyl-phenylalanine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaudreault, RC; Levesque, L; Marceau, F | 2 |
| Gray, GD; Ohlmann, GM | 1 |
| Palmer, RM; Salmon, JA | 1 |
| Giroud, JP; Hakim, J; Périanin, A | 1 |
| Hakim, J; Labro, MT; Perianin, A; Torres, M | 1 |
| Hakim, J; Labro, MT; Perianin, A | 1 |
| Dahinden, C; Fehr, J | 1 |
8 other study(ies) available for phenylbutazone and n-formylmethionine leucyl-phenylalanine
| Article | Year |
|---|---|
Comparison of two classes of non-peptide drugs as antagonists of neutrophil receptors for f-Met-Leu-Phe. Pyrazolons and iodinated radiographic contrast agents.
Topics: Binding, Competitive; Contrast Media; Diatrizoate; Dinoprostone; Glucuronidase; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenylbutazone; Radioligand Assay; Receptors, Formyl Peptide; Receptors, Immunologic; Superoxides | 1992 |
The interaction of 3,5-pyrazolidinedione drugs with receptors for f-Met-Leu-Phe on human neutrophil leukocytes: a study of the structure-activity relationship.
Topics: Binding, Competitive; Cell Survival; Dinoprostone; Fibroblasts; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenylbutazone; Prostaglandins; Receptors, Formyl Peptide; Receptors, Immunologic; Structure-Activity Relationship; Sulfinpyrazone; Superoxides; Tumor Cells, Cultured | 1991 |
Countergradients of nonchemotactic ligands for N-formylmethionylleucylphenylalanine (FMLP) receptors promote FMLP-induced chemotaxis.
Topics: Binding, Competitive; Chemotaxis, Leukocyte; Fusidic Acid; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenylbutazone; Receptors, Formyl Peptide; Receptors, Immunologic; Rifampin; Sulfasalazine; Sulfinpyrazone | 1986 |
Comparison of the effects of some compounds on human neutrophil degranulation and leukotriene B4 and thromboxane B2 synthesis.
Topics: Arachidonic Acids; Aspirin; Calcimycin; Humans; In Vitro Techniques; Indomethacin; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenylbutazone; Thromboxane B2; Thromboxanes | 1985 |
Nonsteroidal anti-inflammatory drug as tools for analysis of neutrophil functions.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood; Chemotaxis, Leukocyte; Complement C5; Complement C5a; Diclofenac; Humans; Indomethacin; Kinetics; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxygen Consumption; Phenylbutazone | 1987 |
The different inhibitory effects of phenylbutazone on soluble and particle stimulation of human neutrophil oxidative burst.
Topics: Humans; Hydrogen Peroxide; Kinetics; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxygen; Oxygen Consumption; Phenylbutazone | 1983 |
Chemokinetic activity of N-formyl-methionyl-leucyl-phenylalanine on human neutrophils, and its modulation by phenylbutazone.
Topics: Chemotaxis, Leukocyte; Humans; Kinetics; Klebsiella pneumoniae; Methionine; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Phenylbutazone; Zymosan | 1982 |
Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
Topics: Agranulocytosis; Arachidonic Acids; Aspirin; Cell Adhesion; Chemotactic Factors; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Humans; Indomethacin; Methionine; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Phenylbutazone; Sulfinpyrazone | 1980 |